Terms: = Leukemia AND IGH
1134 results:
1. Diverse B-cell tumors associated with t(14;19)(q32;q13)/igh::BCL3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract] [Full Text] [Related]
2. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract] [Full Text] [Related]
3. Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation.
Garimberti E; Federico C; Ragusa D; Bruno F; Saccone S; Bridger JM; Tosi S
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397052
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
[TBL] [Abstract] [Full Text] [Related]
5. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
[TBL] [Abstract] [Full Text] [Related]
6. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.
Zhang C; Stelloo E; Barrans S; Cucco F; Jiang D; Tzioni MM; Chen Z; Li Y; Swennenhuis JF; Makker J; Rásó-Barnett L; Liu H; El-Daly H; Soilleux E; Shah N; Nagumantry SK; Kyaw M; Prahladan MP; Tooze R; Westhead DR; Feitsma H; Davies AJ; Burton C; Johnson PWM; Du MQ
Leukemia; 2024 Mar; 38(3):621-629. PubMed ID: 38184753
[TBL] [Abstract] [Full Text] [Related]
7. B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination.
Schichman SA; Penton AL; Ghanta SN; Konda M; Papenhausen PR
J Hematop; 2023 Jun; 16(2):111-117. PubMed ID: 38175445
[TBL] [Abstract] [Full Text] [Related]
8. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
[TBL] [Abstract] [Full Text] [Related]
9. Transcription factor 12-mediated self-feedback regulatory mechanism is required in DUX4 fusion leukaemia.
Li Z; Jiang M; Wang J; Zhuo Z; Zhang S; Tan Y; Hu W; Zhang H; Meng G
Clin Transl Med; 2023 Dec; 13(12):e1514. PubMed ID: 38115701
[TBL] [Abstract] [Full Text] [Related]
10. Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
Liu Y; Ho C; Yu W; Huang Y; Miller J; Gao Q; Syed M; Ma Y; Wang M; Maciag L; Petrova-Drus K; Zhu M; Yao J; Vanderbilt C; Durham B; Benhamida J; Ewalt MD; Dogan A; Roshal M; Nafa K; Arcila ME
J Mol Diagn; 2024 Mar; 26(3):168-178. PubMed ID: 38103591
[TBL] [Abstract] [Full Text] [Related]
11. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an igh deletion.
Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
[TBL] [Abstract] [Full Text] [Related]
12. [Comprehensive Diagnosis of Mantle Cell Lymphoma].
Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
[TBL] [Abstract] [Full Text] [Related]
13. How Many Tests Does It Take to Diagnose a Triple-Hit B-Lymphoblastic Lymphoma? (Hint, It's A Lot).
Das M; Tsuchiya KD; Bohling SD; Davis B; Hwang S; Gardner RA; Chisholm KM
Pediatr Dev Pathol; 2024; 27(2):193-197. PubMed ID: 38032739
[TBL] [Abstract] [Full Text] [Related]
14. Novel identification of t(14;18)(q32;q21)/igh::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
15. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
[TBL] [Abstract] [Full Text] [Related]
16. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
[TBL] [Abstract] [Full Text] [Related]
17. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
[TBL] [Abstract] [Full Text] [Related]
18.
Carbo-Meix A; Guijarro F; Wang L; Grau M; Royo R; Frigola G; Playa-Albinyana H; Buhler MM; Clot G; Duran-Ferrer M; Lu J; Granada I; Baptista MJ; Navarro JT; Espinet B; Puiggros A; Tapia G; Bandiera L; De Canal G; Bonoldi E; Climent F; Ribera-Cortada I; Fernandez-Caballero M; De la Banda E; Do Nascimento J; Pineda A; Vela D; Rozman M; Aymerich M; Syrykh C; Brousset P; Perera M; Yanez L; Ortin JX; Tuset E; Zenz T; Cook JR; Swerdlow SH; Martin-Subero JI; Colomer D; Matutes E; Bea S; Costa D; Nadeu F; Campo E
Haematologica; 2024 Feb; 109(2):493-508. PubMed ID: 37560801
[TBL] [Abstract] [Full Text] [Related]
19. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
[No Abstract] [Full Text] [Related]
[Next]